These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9449877)

  • 1. Intravenous immunoglobulins and transforming growth factor beta.
    Kekow J; Reinhold D; Pap T; Ansorge S
    Lancet; 1998 Jan; 351(9097):184-5. PubMed ID: 9449877
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy.
    Stein LD; Roifman CM
    Bull Rheum Dis; 1995 Jun; 44(4):3-5. PubMed ID: 7787963
    [No Abstract]   [Full Text] [Related]  

  • 3. Levels of serum transforming growth factor-beta1 do not increase in Behçet's disease, in contrast to rheumatoid arthritis.
    Eksioglu-Demiralp E; Direskeneli H; Akoglu T
    J Rheumatol; 1999 Apr; 26(4):1010-1. PubMed ID: 10229441
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acquired factor VIII inhibitor in a patient with rheumatoid arthritis].
    Ruiz-Calderón AJ; Carrasco F; Duro R; Constantino M
    Sangre (Barc); 1993 Oct; 38(5):403-5. PubMed ID: 8140505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenous immunoglobulins on disease activity and cytokine plasma levels in rheumatoid arthritis.
    Pap T; Reinhold D; Kekow J
    Scand J Rheumatol; 1998; 27(2):157-9. PubMed ID: 9572646
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulins and transforming growth factor beta.
    van Schaik IN; Vermeulen M; Brand A
    Lancet; 1998 Apr; 351(9111):1288. PubMed ID: 9643776
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased blood plasma concentrations of TGF-beta isoforms after treatment with intravenous immunoglobulins (i.v.IG) in patients with multiple sclerosis.
    Reinhold D; Perlov E; Schrecke K; Kekow J; Brune T; Sailer M
    J Neuroimmunol; 2004 Jul; 152(1-2):191-4. PubMed ID: 15223252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased blood plasma concentrations of TGF-beta1 and TGF-beta2 after treatment with intravenous immunoglobulins in childhood autoimmune diseases.
    Rissmann A; Pieper S; Adams I; Brune T; Wiemann D; Reinhold D
    Pediatr Allergy Immunol; 2009 May; 20(3):261-5. PubMed ID: 18761651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin treatment of rheumatoid arthritis-associated immunodeficiency.
    Savery F
    Clin Ther; 1988; 10(5):527-9. PubMed ID: 2856595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatology and Autoimmunity in The Israel Medical Association Journal (IMAJ): 2017.
    Vadasz Z
    Isr Med Assoc J; 2017 Dec; 19(12):781-783. PubMed ID: 29235744
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous immunoglobulins in autoimmune diseases].
    Baschieri L
    Clin Ter; 1992 Sep; 141(9 Pt 2):5-6. PubMed ID: 1468199
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural killer T cells and rheumatoid arthritis: friend or foe?
    Elewaut D
    Arthritis Res Ther; 2005; 7(2):88-9. PubMed ID: 15743495
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intravenous immunoglobulins (IgIV) in the treatment of autoimmune diseases and systemic inflammatory diseases].
    Kazatchkine M
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):209-10. PubMed ID: 8337128
    [No Abstract]   [Full Text] [Related]  

  • 14. [New strategies in the immunotherapy of autoimmune diseases].
    Lorenz HM; Geiler T
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous immunoglobulins in Still's disease: still controversial, still unproven.
    Prieur AM
    J Rheumatol; 1996 May; 23(5):797-800. PubMed ID: 8724286
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia.
    Ponchel F; Verburg RJ; Bingham SJ; Brown AK; Moore J; Protheroe A; Short K; Lawson CA; Morgan AW; Quinn M; Buch M; Field SL; Maltby SL; Masurel A; Douglas SH; Straszynski L; Fearon U; Veale DJ; Patel P; McGonagle D; Snowden J; Markham AF; Ma D; van Laar JM; Papadaki HA; Emery P; Isaacs JD
    Arthritis Res Ther; 2005; 7(1):R80-92. PubMed ID: 15642146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different modes of action of high-dose immunoglobulins in rheumatoid arthritis.
    Delire M
    Acta Univ Carol Med (Praha); 1994; 40(1-4):95-9. PubMed ID: 9355681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indication for use and mechanisms of action of intravenous immune globulin in autoimmune diseases].
    Cohen AD; Shoenfeld Y
    Harefuah; 1995 Aug; 129(3-4):123-7. PubMed ID: 8543238
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.
    Kazatchkine MD; Kaveri SV
    N Engl J Med; 2001 Sep; 345(10):747-55. PubMed ID: 11547745
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of transforming growth factor-beta in sputum from patients with bronchial asthma by eosinophil survival assay and enzyme-linked immunosorbent assay.
    Adachi T; Motojima S; Hirata A; Fukuda T; Kihara N; Makino S
    Clin Exp Allergy; 1996 May; 26(5):557-62. PubMed ID: 8735868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.